IVF Access and Affordability Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The IVF Access and Affordability Act (H.R. 9269) was a bill introduced in the 118th Congress aimed at addressing issues related to in vitro fertilization (IVF) access and affordability. Although the official summary and full text are not available, the bill was categorized under the policy area of Taxation, suggesting it involved tax-related provisions to support IVF services. The latest recorded action was its referral to the Subcommittee on Health on December 17, 2024. The bill status is marked as Failed / Expired, indicating it did not advance into law during the session.
H.R. 9269 sought to improve IVF access and affordability through tax-related measures but did not progress beyond subcommittee referral and ultimately expired without enactment.
- The bill was introduced in the House during the 118th Congress and focused on IVF access and affordability.
- It was assigned to the policy area of Taxation, implying tax incentives or credits may have been proposed to reduce IVF costs.
- The bill was referred to the Subcommittee on Health but did not advance further and expired without becoming law.
['Individuals and families seeking IVF treatment who may benefit from reduced financial barriers.', 'Healthcare providers and clinics offering IVF services potentially experiencing increased demand.', 'Taxpayers who may receive tax credits or deductions related to IVF expenses if the bill had passed.']
['Lack of available full bill text limits understanding of specific provisions and implementation mechanisms.', 'Potential fiscal impact on federal revenue due to tax-related incentives or credits.', 'Oversight and enforcement mechanisms are unclear due to missing detailed legislative language.', "The bill's failure to advance may reflect challenges in legislative support or competing priorities."]
The bill was introduced during the 118th Congress and referred to the Subcommittee on Health, indicating initial committee consideration. Its classification under Taxation suggests it was part of broader efforts to address healthcare affordability through fiscal policy. The bill ultimately expired without passage, which is common for many proposed bills that do not secure sufficient legislative momentum.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, tax incentives for IVF could increase demand for fertility services, potentially impacting healthcare providers and insurance markets.', 'Changes in tax policy related to IVF might influence employer-sponsored health plans and coverage decisions.', 'Increased access to IVF could have demographic effects by affecting family planning choices.']
The absence of an official summary and full bill text limits transparency and public understanding of the bill's specific provisions and potential impacts. Tracking the bill's referral to the Subcommittee on Health provides insight into its legislative progress, but the failure to advance highlights the importance of monitoring committee actions and bill status updates for comprehensive oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.